(Q36266976)

13 August 2017

1 reference

title

Anticopper therapy against cancer and diseases of inflammation and fibrosis (English)

1 reference

13 August 2017

0 references

George J Brewer

1

1 reference

13 August 2017

publication date

1 August 2005

1 reference

13 August 2017

1 reference

13 August 2017

volume

10

1 reference

13 August 2017

issue

16

1 reference

13 August 2017

page(s)

1103-1109

1 reference

Treatment of Wilson Disease With Ammonium Tetrathiomolybdate

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903541-5

7 January 2021

Treatment of Wilson's disease with zinc: XV long-term follow-up studies

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903541-5

7 January 2021

Penicillamine, a new oral therapy for Wilson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903541-5

7 January 2021

Treatment of Wilson's disease with trientine (triethylene tetramine) dihydrochloride

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903541-5

7 January 2021

Tumor angiogenesis: therapeutic implications

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903541-5

7 January 2021

Copper control as an antiangiogenic anticancer therapy: lessons from treating Wilson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903541-5

7 January 2021

Cancer therapy with tetrathiomolybdate: antiangiogenesis by lowering body copper--a review

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903541-5

7 January 2021

Copper deficiency as an anti-cancer strategy

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903541-5

7 January 2021

Suppression of tumor recurrence and metastasis by a combination of the PHSCN sequence and the antiangiogenic compound tetrathiomolybdate in prostate carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903541-5

7 January 2021

The role of copper suppression as an antiangiogenic strategy in head and neck squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903541-5

7 January 2021

Inhibition of the growth of squamous cell carcinoma by tetrathiomolybdate-induced copper suppression in a murine model

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903541-5

7 January 2021

Radiotherapy and antiangiogenic TM in lung cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903541-5

7 January 2021

Tetrathiomolybdate therapy protects against bleomycin-induced pulmonary fibrosis in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903541-5

7 January 2021

Inhibition of key cytokines by tetrathiomolybdate in the bleomycin model of pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903541-5

7 January 2021

Tetrathiomolybdate therapy protects against concanavalin a and carbon tetrachloride hepatic damage in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903541-5

7 January 2021

A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903541-5

7 January 2021

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903541-5

7 January 2021

Effects of tetrathiomolybdate in a mouse model of retinal neovascularization

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903541-5

7 January 2021

Tetrathiomolybdate anticopper therapy for Wilson's disease inhibits angiogenesis, fibrosis and inflammation.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903541-5

7 January 2021

Lung cytokine production in bleomycin-induced pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903541-5

7 January 2021

Differential expression of mouse hepatic transporter genes in response to acetaminophen and carbon tetrachloride

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903541-5

7 January 2021

Immunopathogenesis of hepatic fibrosis in chronic liver injury induced by repeatedly administered concanavalin A

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903541-5

7 January 2021

A new job for dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903541-5

7 January 2021

D-penicillamine is not an effective treatment in systemic sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903541-5

7 January 2021

Regeneration of the heart in diabetes by selective copper chelation

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903541-5

7 January 2021

Neurovascular dysfunction in diabetic rats. Potential contribution of autoxidation and free radicals examined using transition metal chelating agents

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903541-5

7 January 2021

SPARC regulates the expression of collagen type I and transforming growth factor-beta1 in mesangial cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903541-5

7 January 2021

SPARC is a source of copper-binding peptides that stimulate angiogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903541-5

7 January 2021

Transforming growth factor beta in tissue fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903541-5

7 January 2021

Dendritic cell regulation of immune responses: a new role for interleukin 2 at the intersection of innate and adaptive immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903541-5

7 January 2021

Interleukin-21 is a T-helper cytokine that regulates humoral immunity and cell-mediated anti-tumour responses

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903541-5

7 January 2021

Endothelial apoptosis induced by oxidative stress through activation of NF-kappaB: antiapoptotic effect of antioxidant agents on endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903541-5

7 January 2021

Inhibition of cytokine-induced NF-kappaB activation by adenovirus-mediated expression of a NF-kappaB super-repressor prevents beta-cell apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903541-5

7 January 2021

Purified monocyte-derived angiogenic substance (angiotropin) stimulates migration, phenotypic changes, and "tube formation" but not proliferation of capillary endothelial cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903541-5

7 January 2021

Interaction of human angiogenin with copper modulates angiogenin binding to endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS1359-6446%2805%2903541-5

7 January 2021

10.1016/S1359-6446(05)03541-5

Identifiers

DOI

1 reference

13 August 2017

1 reference